| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |